Publication | Open Access

Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo

Novel Oncolytic AdenovirusMedicineMelanomaImmunologyEnhanced Antitumor EfficacyImmune Checkpoint InhibitorAnti-cancer AgentOncologyRadiation OncologyCancer-associated Virus